Company Profile
Immix Biopharma Stock Price, News & Analysis
- Ticker:
- IMMX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Immix Biopharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
9.91 USD (+5.43%)
Close
Last updated: June 23, 2026 at 00:00
705.49M USD
Market cap
Why the stock is moving
IMMX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Immix Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Immix Biopharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Immix Biopharma follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Immix Biopharma sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
Source: Immix Biopharma
- 02
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock
Source: Immix Biopharma
- 03
- 04
- 05
Immix Biopharma Announces Proposed Public Offering of Common Stock
Source: Immix Biopharma
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Immix Biopharma (IMMX)?
Immix Biopharma (IMMX) most recently closed at 9.91 USD, a +5.43% move versus the previous session.
What is the market cap of Immix Biopharma (IMMX)?
Immix Biopharma currently has a market capitalization of 705.49M USD on BioPharmSignal.
What does Immix Biopharma do?
Immix Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is IMMX stock listed?
Immix Biopharma (IMMX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Immix Biopharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Immix?
Immix Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Immix Biopharma targeting with Immix?
Immix Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biopharma?
Immix Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.